Related Experiment Video
Updated: Aug 11, 2026

07:46
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Antimicrobial therapy of streptococcal endocarditis
1Mayo Clinic and Foundation, Rochester, Minnesota.
The Journal of Antimicrobial Chemotherapy
|September 1, 1987
Summary
Penicillin combined with aminoglycosides offers effective treatment for streptococcal and enterococcal endocarditis. Duration varies based on specific bacteria and infection characteristics, with relapses requiring extended therapy.
Area of Science:
- Infectious Diseases
- Cardiology
- Pharmacology
Background:
- Endocarditis remains a significant infection, particularly those caused by viridans streptococci and enterococci.
- Optimal antimicrobial regimens are crucial for successful patient outcomes.
Purpose of the Study:
- To outline effective treatment durations and antibiotic combinations for specific types of endocarditis.
- To provide guidance on managing nutritionally variant streptococcal and enterococcal endocarditis.
Main Methods:
- Review of treatment protocols for bacterial endocarditis.
- Analysis of penicillin and aminoglycoside combination therapy efficacy.
- Consideration of infection duration and valve involvement in treatment length.
Main Results:
- Two-week penicillin and aminoglycoside therapy is effective for susceptible viridans streptococci/Streptococcus bovis endocarditis.
- Four-week treatment is recommended for nutritionally variant streptococcal endocarditis.
- Four to six weeks of therapy are indicated for enterococcal endocarditis, adjusted for infection duration and valve site.
Conclusions:
- Tailored antimicrobial therapy duration based on causative organism and clinical factors is essential for endocarditis.
- Penicillin and aminoglycoside combinations provide a robust treatment strategy.
- Extended therapy may be necessary for relapsed or complex enterococcal endocarditis cases.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis I: Introduction
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

